期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Dual-engineered cartilage-targeting extracellular vesicles derived from mesenchymal stem cells enhance osteoarthritis treatment via miR-223/NLRP3/pyroptosis axis:Toward a precision therapy 被引量:1
1
作者 Weixuan Liu Anqi Liu +9 位作者 Xujun Li ziyang sun Zhenghua sun Yaru Liu Gang Wang Dan Huang Hao Xiong Shiyang Yu Xintao Zhang Cunyi Fan 《Bioactive Materials》 SCIE CSCD 2023年第12期169-183,共15页
Osteoarthritis(OA)is the most common disabling joint disease with no effective disease modifying drugs.Extracellular vesicles released by several types of mesenchymal stem cells could promote cartilage repair and amel... Osteoarthritis(OA)is the most common disabling joint disease with no effective disease modifying drugs.Extracellular vesicles released by several types of mesenchymal stem cells could promote cartilage repair and ameliorate OA pathology in animal models,representing a novel therapeutic strategy.In this study,we demonstrated that extracellular vesicles derived from human umbilical cord mesenchymal stem cells(hUC-EVs)could maintain chondrocyte homeostasis and alleviate OA,and further revealed a novel molecular mechanism of this therapeutic effect.miR-223,which could directly bind with the 3′UTR of NLRP3 mRNA,was found to be a key miRNA for hUC-EVs to exert beneficial effects on inflammation inhibiting and cartilage protecting.For enhancing the effect on mitigating osteoarthritis,exogenous miR-223 was loaded into hUC-EVs by electroporation,and a collagen II-targeting peptide(WYRGRL)was modified onto the surface of hUC-EVs by genetic engineering to achieve a more targeted and efficient RNA delivery to the cartilage.The dual-engineered EVs showed a maximal effect on inhibiting the NLRP3 inflammasome activation and chondrocyte pyroptosis,and offered excellent results for the treatment of OA.This study provides a novel theoretical basis and a promising therapeutic strategy for the application of engineered extracellular vesicles in OA treatment. 展开更多
关键词 OSTEOARTHRITIS Extracellular vesicles NLRP3 inflammasome PYROPTOSIS Cartilage-targeting
原文传递
Chemical Modification of Silk Proteins: Current Status and Future Prospects 被引量:4
2
作者 Haoran Liu ziyang sun Chengchen Guo 《Advanced Fiber Materials》 SCIE EI 2022年第4期705-719,共15页
Silk extracted from the cocoon of silkworm has been used as textile materials for thousands of years.Recently,silk has been redefined as a protein-based biomaterial with great potential in biomedical applications owin... Silk extracted from the cocoon of silkworm has been used as textile materials for thousands of years.Recently,silk has been redefined as a protein-based biomaterial with great potential in biomedical applications owing to its excellent mechanical properties,biocompatibility,and biodegradability.With the advances in silk processing technologies,a broad range of intriguing silk-based functional biomaterials have been made and applied for various biomedical uses.However,most of these materials are based on natural silk proteins without chemical modification,leading to limited control of properties and functions(e.g.,biodegradability and bioactivity).A chemical toolbox for modifying the silk proteins is required to achieve versatile silk-based materials with precisely designed properties or functions for different applications.Furthermore,inspired by the traditional fine chemical industry based on synthetic chemistry,developing silk-based fine chemicals with special functions can significantly extend the applications of silk materials,particularly in biomedical fields.This review summarizes the recent progress on chemical modification of silk proteins,focusing on the methodologies and applications.We also discuss the challenges and opportunities of these chemically modified silk proteins. 展开更多
关键词 Silk proteins Chemical modification BIOMATERIALS Fine chemicals Biomedical applications
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部